DJ-1基因与帕金森病

帕金森病是仅次于阿尔茨海默病的第二大神经退行性疾病。DJ-1基因的突变可以引起常染色体隐性遗传性帕金森病。该文将从DJ-1基因及DJ-1蛋白的结构,组织分布,及其在帕金森病发病机制中的功能等方面进行阐述,为研制开发帕金森病的治疗药物提供新的思路。     

Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases

Although oxidative stress has been strongly implicated in the pathogenesis of Alzheimer disease (AD) and Parkinson disease (PD), the identities of specific protein targets of oxidative damage remain largely unknown. Here, we report that Cu,Zn-superoxide dismutase (SOD1), a key antioxidant enzyme whose mutations have been linked to autosomal dominant neurodegenerative disorder familial amyotrophic lateral sclerosis (ALS), is a major target of oxidative damage in AD and PD brains. By using a combination of two-dimensional gel electrophoresis, immunoblot analysis, and mass spectrometry, we have identified four human brain SOD1 isoforms with pI values of 6.3, 6.0, 5.7, and 5.0, respectively. Of these, the SOD1 pI 6.0 isoform is oxidatively modified by carbonylation, and the pI 5.0 isoform is selectively accumulated in AD and PD. Moreover, Cys-146, a cysteine residue of SOD1 that is mutated in familial ALS, is oxidized to cysteic acid in AD and PD brains. Quantitative Western blot analyses demonstrate that the total level of SOD1 isoforms is significantly increased in both AD and PD. Furthermore, immunohistochemical and double fluorescence labeling studies reveal that SOD1 forms proteinaceous aggregates that are associated with amyloid senile plaques and neurofibrillary tangles in AD brains. These findings implicate, for the first time, the involvement of oxidative damage to SOD1 in the pathogenesis of sporadic AD and PD. This work suggests that AD, PD, and ALS may share a common or overlapping pathogenic mechanism(s) that could potentially be targeted by similar therapeutic strategies.     

SREBF1 links lipogenesis to mitophagy and sporadic Parkinson disease

Mitochondrial quality control has an impact on many diseases, but intense research has focused on the action of 2 genes linked to heritable forms of Parkinson disease (PD), PINK1 and PARK2/parkin, which act in a common pathway to promote mitophagy. However, criticism has been raised that little evidence links this mechanism to sporadic PD. To gain a greater insight into the mechanisms of PINK1-PARK2 mediated mitophagy, we undertook a genome-wide RNAi screen in Drosophila and human cell models. Strikingly, we discovered several components of the lipogenesis pathway, including SREBF1, playing a conserved role in mitophagy. Our results suggest that lipids influence the stabilization of PINK1 during the initiation of mitophagy. Importantly, SREBF1 has previously been identified as a risk locus for sporadic PD, and thus implicates aberrant mitophagy as contributing to sporadic PD. Our findings suggest a role for lipid synthesis in PINK1-PARK2 mediated mitophagy, and propose a mechanistic link between familial and sporadic PD, supporting a common etiology.     

SREBF1 links lipogenesis to mitophagy and sporadic Parkinson disease

Mitochondrial quality control has an impact on many diseases, but intense research has focused on the action of 2 genes linked to heritable forms of Parkinson disease (PD), PINK1 and PARK2/parkin, which act in a common pathway to promote mitophagy. However, criticism has been raised that little evidence links this mechanism to sporadic PD. To gain a greater insight into the mechanisms of PINK1-PARK2 mediated mitophagy, we undertook a genome-wide RNAi screen in Drosophila and human cell models. Strikingly, we discovered several components of the lipogenesis pathway, including SREBF1, playing a conserved role in mitophagy. Our results suggest that lipids influence the stabilization of PINK1 during the initiation of mitophagy. Importantly, SREBF1 has previously been identified as a risk locus for sporadic PD, and thus implicates aberrant mitophagy as contributing to sporadic PD. Our findings suggest a role for lipid synthesis in PINK1-PARK2 mediated mitophagy, and propose a mechanistic link between familial and sporadic PD, supporting a common etiology.     

Oxidative damage to macromolecules in human Parkinson disease and the rotenone model

Parkinson disease (PD), the most common neurodegenerative movement disorder, is associated with selective degeneration of nigrostriatal dopamine neurons. Although the underlying mechanisms contributing to neurodegeneration in PD seem to be multifactorial, mitochondrial impairment and oxidative stress are widely considered to be central to many forms of the disease. Whether oxidative stress is a cause or a consequence of dopaminergic death, there is substantial evidence for oxidative stress both in human PD patients and in animal models of PD, especially using rotenone, a complex I inhibitor. There are many indices of oxidative stress, but this review covers the recent evidence for oxidative damage to nucleic acids, lipids, and proteins in both the brain and the peripheral tissues in human PD and in the rotenone model. Limitations of the existing literature and future perspectives are discussed. Understanding how each particular macromolecule is damaged by oxidative stress and the interplay of secondary damage to other biomolecules may help us design better targets for the treatment of PD.     

Structural effects of Parkinson's disease linked DJ-1 mutations

Mutations in the protein DJ-1 are associated with familial forms of Parkinson's disease, indicating that DJ-1 may be involved in pathways related to the etiology of this disorder. Here we have used solution state NMR and circular dichroism spectroscopies to evaluate the extent of structural perturbations associated with five different Parkinson's disease linked DJ-1mutations: L166P, E64D, M26I, A104T, and D149A. Comparison of the data with those obtained for the wild-type protein shows that the L166P mutation leads to severe and global destabilization and unfolding of the protein structure, while the structure of the E64D mutation, as expected, is nearly unperturbed. Interestingly, the remaining three mutants all show different degrees of structural perturbation, which are accompanied by a reduction in the thermodynamic stability of the protein. The observed structural and thermodynamic differences are likely to underlie any functional variations between these mutants and the wild type, which in turn are likely responsible for the pathogenicity of these mutations.     

Reduced protein stability of human DJ-1/PARK7 L166P, linked to autosomal recessive Parkinson disease, is due to direct endoproteolytic cleavage by the proteasome

Parkinson's disease (PD) is characterized by dopaminergic dysfunction and degeneration. DJ-1/PARK7 mutations have been linked with a familial form of early onset PD. In this study, we found that human DJ-1 wild type and the missense mutants M26I, R98Q, A104T and D149A were stable proteins in cells, only the L166P mutant was unstable. In parallel, the former were not degraded and the L166P mutant was directly degraded in vitro by proteasome-mediated endoproteolytic cleavage. Furthermore, genetic evidence in fission yeast showed the direct involvement of proteasome in the degradation of human DJ-1 L166P and the corresponding L169P mutant of SPAC22E12.03c, the human orthologue of DJ-1 in Schizosaccharomyces Pombe, as their protein levels were increased at restrictive temperature in fission yeast (mts4 and pts1-732) harboring temperature sensitive mutations in proteasomal subunits. In total, our results provide evidence that direct proteasomal endoproteolytic cleavage of DJ-1 L166P is the mechanism of degradation contributing to the loss-of-function of the mutant protein, a property not shared by other DJ-1 missense mutants associated with PD.     

Oxidative damage to surfactant protein D in pulmonary diseases

Surfactant protein D is an important innate host defence molecule that has been shown to interact with a variety of pathogens and to play a role in surfactant homeostasis. The aim of this study was to examine the influence of oxidation on surfactant protein D in different lung diseases. Bronchoalveolar lavage fluids (BALFs) from patients with different grade of protein oxidation were examined for changes in the primary chain and the quaternary structure of surfactant protein D. Significant changes of quaternary surfactant protein-D (SP-D) structure were detected under oxidative conditions in vitro and in vivo. The functional capacity of surfactant protein D to agglutinate bacteria was impaired by oxidation. We conclude that surfactant protein D is an important target of free radicals generated in the lungs. Host defence may be impaired due to the oxidation of surfactant protein D and may contribute to the suppurative lung diseases like cystic fibrosis (CF).     

Parkinson Disease Protein DJ-1 Binds Metals and Protects against Metal-induced Cytotoxicity

The progressive loss of motor control due to reduction of dopamine-producing neurons in the substantia nigra pars compacta and decreased striatal dopamine levels are the classically described features of Parkinson disease (PD). Neuronal damage also progresses to other regions of the brain, and additional non-motor dysfunctions are common. Accumulation of environmental toxins, such as pesticides and metals, are suggested risk factors for the development of typical late onset PD, although genetic factors seem to be substantial in early onset cases. Mutations of DJ-1 are known to cause a form of recessive early onset Parkinson disease, highlighting an important functional role for DJ-1 in early disease prevention. This study identifies human DJ-1 as a metal-binding protein able to evidently bind copper as well as toxic mercury ions in vitro. The study further characterizes the cytoprotective function of DJ-1 and PD-mutated variants of DJ-1 with respect to induced metal cytotoxicity. The results show that expression of DJ-1 enhances the cells'' protective mechanisms against induced metal toxicity and that this protection is lost for DJ-1 PD mutations A104T and D149A. The study also shows that oxidation site-mutated DJ-1 C106A retains its ability to protect cells. We also show that concomitant addition of dopamine exposure sensitizes cells to metal-induced cytotoxicity. We also confirm that redox-active dopamine adducts enhance metal-catalyzed oxidation of intracellular proteins in vivo by use of live cell imaging of redox-sensitive S3roGFP. The study indicates that even a small genetic alteration can sensitize cells to metal-induced cell death, a finding that may revive the interest in exogenous factors in the etiology of PD.     

A new evolutionary paradigm for the Parkinson disease gene DJ-1

The DJ-1 gene is extensively studied because of its involvement in familial Parkinson disease. DJ-1 belongs to a complex superfamily of genes that includes both prokaryotic and eukaryotic representatives. We determine that many prokaryotic groups, such as proteobacteria, cyanobacteria, spirochaetes, firmicutes, or fusobacteria, have genes, often incorrectly called "Thij," that are very close relatives of DJ-1, to the point that they cannot be clearly separated from the eukaryotic DJ-1 genes by phylogenetic analyses of their sequences. In addition, and contrary to a previous study that suggested that DJ-1 genes were animal specific, we show that DJ-1 genes are found in at least 5 of the 6 main eukaryotic groups: opisthokonta (both animals and fungi), plantae, chromalveolata, excavata, and amoebozoa. Our results thus provide strong evidence for DJ-1 genes originating before the origin of eukaryotes. Interestingly, we found that some fungal species, among them the model yeast Schizosaccharomyces pombe, have DJ-1-like genes, most likely orthologous to the animal genes. This finding opens new ways for the analysis of the functions of this group of genes.     

Oxidative damage in Parkinson disease: Measurement using accurate biomarkers

Oxidative damage has been implicated in the pathogenesis of Parkinson disease (PD) but the literature data are confusing. Using products of lipid and DNA oxidation measured by accurate methods, we assessed the extent of oxidative damage in PD patients. The levels of plasma F₂-isoprostanes (F₂-IsoPs), hydroxyeicosatetraenoic acid products (HETEs), cholesterol oxidation products, neuroprostanes (F₄-NPs), phospholipase A₂ (PLA₂) and platelet activating factor–acetylhydrolase (PAF-AH) activities, urinary 8-hydroxy-2′-deoxyguanosine (8-OHdG), and serum high-sensitivity C-reactive protein were compared in 61 PD patients and 61 age-matched controls. The levels of plasma F₂-IsoPs, HETEs, 7β-and 27-hydroxycholesterol, 7-ketocholesterol, F₄-NPs, and urinary 8-OHdG were elevated, whereas the levels of plasma PLA₂ and PAF-AH activities were lower, in PD patients compared to controls (p <  0.05). The levels of plasma F₂-IsoPs, HETEs, and urinary 8-OHdG were higher in the early stages of PD (p trend <  0.05). There was a significant negative correlation between the cumulative intake of levodopa and urinary 8-OHdG (r =  ?0.305, p =  0.023) and plasma total HETEs (r =  ?0.285, p =  0.043). Oxidative damage markers are systemically elevated in PD, which may give clues about the relation of oxidative damage to the onset and progression of PD.     

ROS removal by DJ-1: Arabidopsis as a new model to understand Parkinson disease

Reactive oxygen species represent one of the principal factors that cause cell death and scavenging of reactive oxygen species by superoxide dismutase-related pathway is essential for cell survival. The Parkinson disease-related DJ-1 protein (also known as PARK7) has been implicated in resistance against oxidative stress in dopaminergic neurons however, its molecular mechanism has to date been unknown. We have used Arabidopsis thaliana as a model system to demonstrate that DJ-1, in both plant and mammalian cells, directly influence SOD activity in a highly conserved manner thereby preventing cell death. These data not only provides evidence for the molecular mechanisms associated with DJ-1-induced Parkinson disease but also highlight the unprecedented value of plants as a tool in understanding human disease mechanisms.Key words: DJ-1, stress, cell death, Parkinson disease, ArabidopsisReactive oxygen species (ROS) are involved in a myriad of fundamental biological processes including cell signaling and cellular defense pathways in plants and animals.^1–3 Despite its role as a signaling molecule, inappropriate and elevated levels of ROS have a major impact on the etiology of neurodegenerative diseases, such as for example Parkinson disease (PD), and in oxidative stress responses in plants. In general ROS can cause damage to DNA, lipids, proteins and various cofactors. During normal physiological conditions, when ROS are continuously generated, antioxidant defense systems are adequately equipped to prevent ROS-induced tissue dysfunction.^4,5 However upon elevated ROS generation the cellular antioxidant systems either recruit additional factors to minimize ROS-induced damage or cells suffer the consequences of cell death. Because of this dichotomy, where ROS plays a vital role during growth and development but can also have overwhelming damaging effects, it is clear that strict regulatory mechanisms need to be in place to effectively control ROS levels. In both plant and mammalian cells elevated ROS levels lead to cell death and in various human disease such as PD, Alzheimer disease, amyotrophic lateral sclerosis and Huntington disease proteins involved in stress-related pathways are often mutated.⁶In both plants and mammals mitochondria act as an important source of ROS however, plants also produce ROS in chloroplasts as part of photosynthetic activity. Combined with the fact that plants are sessile organisms it suggests that, although similar in nature, plants most probably have more complex antioxidant systems than other organisms.Strategies for removing excess ROS are similar in plants and humans. The principle ROS removal pathway involves superoxide dismutases (SOD) (or copper/zinc superoxide dismutase-CSD in plants), glutathione peroxidases (GPX) and catalases (CAT) localized in the cytosol, mitochondria and chloroplasts (Fig. 1). SOD converts superoxide anion to H₂O₂, which is then detoxified to H₂O by GPX and CAT. In Arabidopsis, besides SOD, GPX and CAT, there are five ascorbate peroxidases (APX) located in the cytosol and chloroplasts, involved in scavenging ROS generated during photosynthesis.^7,8 Therefore, SOD, GPX, CAT and APX, together with other auxiliary proteins, form the main line of defense against ROS.Open in a separate windowFigure 1Involvement of DJ-1-like proteins in ROS scavenging pathways. Produced O₂^- is converted to H₂O₂ by SOD in human or CSD (Arabidopsis SOD) in Arabidopsis. H₂O₂ is then converted to H₂O by GPX or CAT (catalase) in human or APX, GPX or CAT in Arabidopsis. DJ-1-like proteins interact with SOD or GPX in humans and CSD, GPX and APX in Arabidopsis. It is assumed here that DJ-1-like proteins may also interact with catalases (broken arrows).DJ-1 was originally identified as an oncogene and represents a ubiquitous redox-responsive cytoprotective protein with diverse functions where one of its main roles have been attributed to oxidative stress protection.⁹ Numerous studies have shown that several DJ-1 mutations in humans cause autosomal recessive, early onset PD however, its mode of action has been elusive in terms of having a direct influence on neuronal cell death.¹⁰ In an attempt to clarify the mechanism of DJ-1 we established Arabidopsis thaliana as a new and novel model system.¹¹ The Arabidopsis genome contains three DJ-1 homologs compared to the single DJ-1 locus found in humans and we showed that two of these (AtDJ-1b and AtDJ-1c) localizes to chloroplasts whilst one, AtDJ-1a, localizes to the cytosol and nucleus as observed for human DJ-1.¹¹ As mutated DJ-1 in mammals leads to cell death we identified and characterized a DJ-1 loss-of-function mutant which showed increased cell death in aging plants. Using Bimolecular Fluorescence Complementation (BiFC) and isothermal titration calorimetry (ITC) assays we showed that AtDJ-1a interacts with CSD1, the cytosolic SOD in Arabidopsis, and with human SOD1 in plant cells. Further we demonstrated that the human DJ-1 protein interacts with SOD1 in mammalian CHO cells.¹¹ Similar approaches were also employed to show that AtDJ-1a and human DJ-1 had an interaction with GPX2 in plant and mammalian cells.¹¹Enzyme assays revealed that AtDJ-1a and DJ-1 stimulated SOD/CSD1 activity and that only the copper-loaded forms of AtDJ-1a and DJ-1 had this effect suggesting that AtDJ-1a/DJ-1 may provide copper for SOD/CSD1.¹¹ Although the observed SOD activation provides clues towards the role of DJ-1 in detoxification of ROS, SOD only converts superoxide anion to H₂O₂ which must further be detoxified to H₂O by GPX and CAT. Although we showed that AtDJ-1a and human DJ-1 can interact with AtGPX2 and GPX2, respectively, we observed no changes in GPX2 activity upon DJ-1 interaction. The reason for this may be several-fold. First, cellular GPX2 activity levels may be sufficient to convert SOD-generated H₂O₂ to H₂O. Second, DJ-1 may indeed have no effect on GPX2 activity but simply act as an anchor to dock GPX2 in the vicinity of SOD. To test whether the DJ-1/SOD/GPX2 complex recruits other auxiliary proteins we have also shown that AtDJ-1a interacts with the Arabidopsis cytosolic APX1 protein (Fig. 2, unpublished data). It is also highly possible that DJ-1 interacts with catalase or at least influences its activity (Fig. 1). Although we have no data to date indicating a functional significance of the DJ-1/APX1 interaction we speculate that DJ-1 indeed acts as a scaffold protein bringing together SOD, GPX and possibly APX1 to mediate and control ROS scavenging, ultimately preventing oxidative stress-induced cell death (Fig. 3).Open in a separate windowFigure 2Interaction of AtDJ-1a with APX1. AtDJ-1a tagged with the N-terminal region of GFP and APX1 tagged with the C-terminal region of GFP gene were co-transformed into tobacco cells. The observed GFP signal in (B) demonstrates an AtDJ-1a/APX1 interaction through reconstitution of functional GFP molecules. (A) Negative control.Open in a separate windowFigure 3Working model of AtDJ-1a and DJ-1 mode of action. AtDJ-1a and DJ-1 interacts with SOD and GPX2 leading to SOD activation in a copper-dependent fashion. It is proposed that AtDJ-1a and DJ-1 delivers copper to SOD enhancing its activity whilst GPX2 is anchored by AtDJ-1 and DJ-1 to the protein complex to ensure conversion of the SOD-generated H₂O₂ to H₂O.The fact that Arabidopsis has three DJ-1 homologs where two of these, AtDJ-1b and AtDJ-1c, are localized to chloroplasts¹¹ underlines the protective role of DJ-1-like proteins during oxidative stress in plants. From our localization studies it appears that AtDJ-1b is localized to the chloroplast stroma whilst AtDJ-1c is localized to both the stroma and the thylakoid membranes (unpublished data). Whether AtDJ-1b and AtDJ-1c act in isolation or in concert and how these two proteins are involved in photosynthesis-induced ROS regulation is unclear but represent exciting future challenges.The notion that plants can be used as tools to increase our understanding of human disease mechanisms is somewhat obscure to the general scientific community. The fact remains that many discoveries with direct relevance to human health and disease have been elaborated using Arabidopsis, and several processes important to human biology are more easily studied in this versatile model plant.¹² The use of Arabidopsis to understand human disease states has several advantages: (1) Arabidopsis represents a well established model organism with a fully annotated genome, (2) The Arabidopsis genome contains homologs of numerous genes involved in human disease, (3) The identification and generation of Arabidopsis mutants is simple and requires little effort, (4) Arabidopsis growth and maintenance requires little infrastructure and running costs and (5) Arabidopsis research has few ethical constraints.Despite the advantages of Arabidopsis as a model system for elucidating human disease mechanisms it is important to appreciate that Arabidopsis and plant research in general can only reach its full potential in the field of medical research if combined with complementary, and perhaps more conventional, model systems.     

Oxidative damage to DNA and antioxidant status in aging and age-related diseases

Aging is a complex process involving morphologic and biochemical changes in single cells and in the whole organism. One of the most popular explanations of how aging occurs at the molecular level is the oxidative stress hypothesis. Oxidative stress leads in many cases to an age-dependent increase in the cellular level of oxidatively modified macromolecules including DNA, and it is this increase which has been linked to various pathological conditions, such as aging, carcinogenesis, neurodegenerative and cardiovascular diseases. It is, however, possible that a number of short-comings associated with gaps in our knowledge may be responsible for the failure to produce definite results when applied to understanding the role of DNA damage in aging and age-related diseases.     

Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease

DJ-1 is an antioxidant protein whose loss of function by gene mutations has been linked to familial Parkinson's disease (PD). The main objective of the present study was to determine if this molecule was also involved in the pathogenesis of sporadic PD. For this purpose, quantitative immunoblot assays were performed to evaluate DJ-1 in cerebrospinal fluids (CSF) collected from sporadic PD patients (n=40) and non-PD controls (n=38). The results showed that the CSF DJ-1 levels in PD were significantly higher than those in non-PD controls. Especially, upregulation of CSF DJ-1 in the early stage of PD (Yahr I-II) were distinct compared to those in the advanced stage of PD (Yahr III-IV) and non-PD controls (p<0.001 by ANOVA with post hoc Bonferroni's test), suggesting a protective role of DJ-1 against oxidative stress during the early stage. Thus, we propose that CSF DJ-1 could be a possible biomarker for early sporadic PD.     

Functional impairment in RHOT1/Miro1 degradation and mitophagy is a shared feature in familial and sporadic Parkinson disease

Mitophagy is a conserved and highly regulated process of selective degradation crucial in maintaining normal cellular physiology. Genetic defects and cellular aberrations affecting mitophagy have been associated with the development of Parkinson disease. In their recently published article (highlighted in a punctum in this issue of the journal) Hsieh et al. present a putative mitophagy marker, which serves as a mechanistic link between sporadic and familial Parkinson disease.     

Neurosecretases provide strategies to treat sporadic and familial Alzheimer disorders

Recent discoveries on neurosecretases and their trafficking to release fibril-forming neuropeptides or other products, are of interest to pathology, cell signaling and drug discovery. Nomenclature arose from the use of amyloid precursor protein (APP) as a prototypic type-1 substrate leading to the isolation of beta-secretase (BACE), multimeric complexes (gamma-secretase, gamma-SC) for intramembranal cleavage, and attributing a new function to well-characterized metalloproteases of the ADAM family (alpha-secretase) for normal APP turnover. While purified alpha/beta-secretases facilitate drug discovery, gamma-SC presents greater challenges for characterization and mechanisms of catalysis. The review comments on links between mutation or polymorphisms in relation to enzyme mechanisms and disease. The association between lipoprotein receptor LRP11 variants and sporadic Alzheimer's disease (SAD) offers scope to integrate components of pre- and post-Golgi membranes, or brain clathrin-coated vesicles within pathways for trafficking as targets for intervention. The presence of APP and metabolites in brain clathrin-coated vesicles as significant cargo with lipoproteins and adaptors focuses attention as targets for therapeutic intervention. This overview emphasizes the importance to develop new therapies targeting neurosecretases to treat a major neurological disorder that has vast economic and social implications.